Ovid brings two Big Phar­ma vets on board as new CMO, head of epilep­sy re­search

Ovid has hired two new se­nior em­ploy­ees to push its pipeline for­ward.

The New York-based, neu­ro-fo­cused biotech put out word Wednes­day morn­ing that it hired Manoj Mal­ho­tra as its chief med­ical of­fi­cer and Toshiya Nishi as its epilep­sy re­search head.

Mal­ho­tra comes to Ovid af­ter his stint at Ei­sai, where he was the head of med­ical af­fairs for Ei­sai’s neu­rol­o­gy busi­ness group. Be­yond Ei­sai, Mal­ho­tra is a neu­rol­o­gist and epilep­tol­o­gist who has had pre­vi­ous roles at Mallinck­rodt, No­var­tis and Take­da.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.